Cancer drug trial halted early: no breakthrough for advanced tumors
NCT ID NCT04892017
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 36 times
Summary
This early-stage trial tested a new drug, DCC-3116, alone or with other targeted therapies, in 91 adults with advanced solid tumors (like lung cancer) that have specific gene mutations. The study was terminated, meaning it stopped early, likely due to safety or lack of benefit. The goal was to find safe doses and see if tumors shrank, but this is not a cure—patients would need ongoing treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
New York, New York, 10016, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
NEXT Oncology
Austin, Texas, 78758, United States
-
NEXT Oncology
San Antonio, Texas, 78229, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Rutgers Cancer Institute
New Brunswick, New Jersey, 08901, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Wisconsin Clinical Science Center
Madison, Wisconsin, 53792, United States
-
Washington University Siteman Cancer Center
St Louis, Missouri, 63108, United States
Conditions
Explore the condition pages connected to this study.